Acute renal failure in the neonate induced by the administration of indomethacin as a tocolytic agent

Nephrology Dialysis Transplantation

Volumn 11, Issue 6, 1996, Pages 1139-1141

  Pomeranz, A ^a   Korzets, Z ^a   Dolfin, Z ^a   Eliakim, A ^a   Bernheim, J ^a,b   Wolach, B ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b MEIR MEDICAL CENTER   (Israel)

Author keywords

Acute renal failure; Indomethacin; Neonate; Tocolytic

Indexed keywords

INDOMETACIN; UTERUS SPASMOLYTIC AGENT;

ACUTE KIDNEY FAILURE; ARTICLE; CASE REPORT; FEMALE; HUMAN; HYDRAMNIOS; MALE; NEWBORN; NEWBORN MORBIDITY; PREMATURE LABOR; PRIORITY JOURNAL;

EID: 0029984763     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.ndt.a027470     Document Type: Article

References (20)

1. King JF, Grant A, Kreise MJ, Chalmers I. Betamimetics in preterm labor: an overview of randomized controlled trials. Br J Obstet Gynecol 1988; 95: 211-222
2. Novy MJ, Ligging GC. Role of prostaglandins, prostacyclin and thromboxanes in the physiologic control of the uterus and in parturition. Semin Perinatol 1980; 4: 45-66
3. Van der Veyver IB, Moise KJ Jr. Prostaglandin synthetase inhibitors in pregnancy. Obstet Gynecol Surv 1993; 48: 493-502
4. Zuckerman H, Reiss U, Rubinstein I. Inhibition of human premature labor by indomethacin. Obstet Gynecol 1974; 44: 787-792
5. Nielby JR, Blake DA, White RD et al. The inhibition of premature labor with indomethacin. Am J Obstet Gynecol 1980; 136: 1014-1019
6. Merrill JD, Clyman RI, Norton ME. Indomethacin as a tocolytic agent. The controversy continues. J Pediatr 1994; 124: 734-736
7. Norton ME, Merrill JD, Cooper BAB, Kuller JA, Clyman RI. Neonatal complications after the administration of indomethacin for preterm labor, N Engl J Med 1993; 329: 1602-1607
8. Eronen M, Peronen E, Kurki T, Teramo K, Ylikorkala O, Hallman M. Increased incidence of bronchopulmonary dysplasia after antenatal administration of indomethacin to prevent preterm labor. J Pediatr 1994; 124: 782-788
9. Moise KJ Jr, Huhta JC, Sharif DS et al. Indomethacin in the treatment of preterm labor. Effect on the fetal ductus. N Engl J Med 1988; 319: 327-331
10. Restaino I, Kaplan BS, Kaplan P, Rosenberg H, Witzleben C, Roberts N. Renal dysgenesis in a monozygotic twin. Association with in utero exposure to indomethacin. Am J Med Genet 1991; 39: 252-257
11. Gloor JN, Muchant DG, Norling LL. Prenatal maternal indomethacin use resulting in prolonged neonatal renal insufficiency. J Perinatol 1993; 13: 425-427
12. Kaplan BS, Restaino I, Raval DS, Gottlieb RP, Bernstein J. Renal failure in the neonate associated with in utero exposure to non-steroidal anti-inflammatory agents. Pediatr Nephrol 1994; 8: 700-704
13. Novy MJ. Effects of indomethacin on labor, fetal oxygenation and fetal development in rhesus monkeys. Adv Prostaglandin Thromboxane Res 1978; 4: 283-300
14. Traeger A, Noschel H, Zaumseil J. Pharmacokinetics of indomethacin in pregnant and parturient women and in their newborn infants. Zentralbl Gynakol 1973; 95: 635-641
15. Klein KL, Scott WJ, Clark KE, Wilson JG. Indomethacin: placental transfer, cytotoxicity and teratology in the rat. Am J Obstet Gynecol 1981; 141: 448-452
16. Cantor B, Tyler T, Nelson RM, Stein GH. Oligohydramnios and transient neonatal anuria: a possible association with the maternal use of prostaglandin synthetase inhibitors. J Reprod Med 1980; 24: 220-223
17. Gomez RA, Pupilli C, Everett AD. Molecular and cellular aspects of renin during kidney ontogeny. Pediatr Nephrol 1991; 5: 80-87
18. Gomez RA, Norwood VF. Developmental consequences of the renin-angiotensin system. Am J Kidney Dis 1995; 26: 409-431
19. Tufro-McReddie A, Johns DW, Geary KM et al. Angiotensin II type 1 receptor: role in renal growth and gene expression during normal development. Am J Physiol (Renal Fluid Electrolyte Physiol) 1994; 266: F911-F918
20. Matson JR, Stokes JB, Robillard JE. Effect of inhibition of prostaglandin synthesis on fetal renal function. Kidney Int 1981; 20: 621-627